Pivotal Study of the Safety and Effectiveness of Autologous Bone Marrow Aspirate Concentrate (BMAC) for the Treatment of Critical Limb Ischemia Due to Peripheral Arterial Disease
Location:
Phoenix/Scottsdale, Ariz., Jacksonville, Fla., Rochester, Minn.
Trial status:
Open for Enrollment
Why is this study being done?
Bone marrow aspirate is collected and processed by centrifugation to remove red blood cells. The resulting concentrate of cells is injected into ischemic tissues of the lower limb. The purpose of this study is to determine if injections of concentrated bone marrow nucleated cells into ischemic tissues will result in vasculogenesis.
NCT ID:
NCT01245335
Who can I contact for additional information about this study?
Rochester: Joseph Hockert 507-293-3496
Scottsdale: Debbie L Ryan 480-342-1208
Jacksonville: Barbara Little, RN 904-953-8361